Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
308,713,740
-
Number of holders
-
286
-
Total 13F shares, excl. options
-
305,140,281
-
Shares change
-
-5,124,130
-
Total reported value, excl. options
-
$2,874,465,217
-
Value change
-
-$56,740,355
-
Put/Call ratio
-
110%
-
Number of buys
-
131
-
Number of sells
-
144
-
Price
-
$9.42
Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q4 2024
As of 31 Dec 2024 AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) had 286 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 305,140,281 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock, Inc., PERCEPTIVE ADVISORS LLC, Avoro Capital Advisors LLC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, STATE STREET CORP, CITADEL ADVISORS LLC, Palo Alto Investors LP, and JPMORGAN CHASE & CO.
This table shows 286 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.